These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9041925)

  • 1. Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma.
    Korenaga D; Saeki H; Mawatari K; Orita H; Maekawa S; Ikeda T; Sugimachi K
    Arch Surg; 1997 Feb; 132(2):188-94. PubMed ID: 9041925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
    Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas.
    Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y
    Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.
    Choi JS; Min JS
    Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
    Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas.
    Koga H; Moriya Y; Akasu T; Fujita S
    Eur J Surg Oncol; 1999 Jun; 25(3):292-6. PubMed ID: 10336810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative carcinoembryonic antigen predicts survival following colorectal cancer surgery with curative intent.
    Gunawardene A; Larsen P; Shekouh A; Dennett E
    ANZ J Surg; 2018 Dec; 88(12):1311-1315. PubMed ID: 30066426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
    Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
    Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
    Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
    Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
    Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
    J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic assessment of carcinoembryonic antigen in the first month after liver resection for colorectal liver metastases as a rapid-recurrence predictor.
    Takamoto T; Sugawara Y; Hashimoto T; Shimada K; Inoue K; Maruyama Y; Makuuchi M
    J Surg Oncol; 2016 Mar; 113(4):463-8. PubMed ID: 27100029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.